Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): Two randomised double-blind, placebo-controlled phase 3 trials

Alan F. Barker, Anne E. O'Donnell, Patrick Flume, Philip J. Thompson, Jonathan D. Ruzi, Javier De Gracia, Wim G. Boersma, Anthony De Soyza, Lixin Shao, Jenny Zhang, Laura Haas, Sandra A. Lewis, Sheila Leitzinger, A. Bruce Montgomery, Matthew T. McKevitt, David Gossage, Alexandra L. Quittner, Thomas G. O'Riordan

Research output: Contribution to journal › Article › peer-review

167 Scopus citations

Fingerprint

Dive into the research topics of 'Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): Two randomised double-blind, placebo-controlled phase 3 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences